Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platinum doublet vs cisplatin chemoradiotherapy for locally advanced cervical cancer
ChiCTR2200063613Phase 3Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin and paclitaxel in Cervical Cancer (CC) (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: Immediate post-treatment efficacy, Immediate post-treatment toxicity and 1 more. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
cisplatinpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2200063613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063613.